Research Paper Volume 16, Issue 2 pp 1879—1896
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 6. GSEA of CDK16 in TCGA pan-cancer. (A–F) The top 6 significant pathways of GSEA results across the indicated tumor types. Red color represents immune-related pathways.